HETEROAROMATIC MODULATORS OF THE RETINOID-RELATED ORPHAN RECEPTOR GAMMA

The present invention relates to a compound according to general formula (I) wherein X represents N or CH; R1 is -CN, (C1-C6)alkyl, (C3-C7)cycloalkyl, (3-7 membered)heterocycloalkyl, (5-6 membered)heteroaryl, (C3-C7)cycloalkyl(C1-C4)alkyl, (3-7 membered)heterocycloalkyl-(C1-C4)alkyl or (5-6 membered...

Full description

Saved in:
Bibliographic Details
Main Authors JOHNSON, Patrick Stephen, MAANSSON, Kristoffer, JESSIMAN, Alan Stuart, SØRENSEN, Morten Dahl
Format Patent
LanguageEnglish
French
Published 18.01.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to a compound according to general formula (I) wherein X represents N or CH; R1 is -CN, (C1-C6)alkyl, (C3-C7)cycloalkyl, (3-7 membered)heterocycloalkyl, (5-6 membered)heteroaryl, (C3-C7)cycloalkyl(C1-C4)alkyl, (3-7 membered)heterocycloalkyl-(C1-C4)alkyl or (5-6 membered)heteroaryl- (C1-C4)alkyl; R2 is halogen, cyano, (C1-C4)alkyl or (C3-C7)cycloalkyl; R3 is halogen, cyano, (C1-C4)alkyl, (C1-C4)haloalkyl or (C3-C7)cycloalkyl; R4 is (C1-C4)alkyl or (C1-C4)haloalkyl; R5 is (C1-C6)alkyl, (C3-C7)cycloalkyl, (C1-C6)alkyl-(C3-C7)cycloalkyl, (C3-C7)cycloalkyl-(C1-C6)alkyl, (3-7 membered)heterocycloalkyl, phenyl, (5-6 membered)heteroaryl or -ORa. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds and to intermediates for preparation of said compounds. La présente invention concerne des composés selon la formule générale (I) où X représente N ou CH; R1 est -CN, (C1-C6alkyle, (C3-C7 cycloalkyle, (3-7 membre)hétérocycloalkyle, (5-6 membre)hétéroaryle, (C3-C7) cycloalkyle (C1-C4 alkyle, (3-7 membre) hétérocycloalkyle-(C1-C4 alkyle ou (5-6 membre) hétéroaryle-(C1-C4 alkyle; R2 est un halogène, un cyano, (C1-C4 alkyle ou (C3-C7 cycloalkyle; R3 est un halogène, un cyano, (C1-C4 alkyle, (C1-C4 haloalkyle ou (C3-C7) cycloalkyle; R4 est (C1-C4 alkyle ou (C1-C4 haloalkyle; R5 est (C1-C6 alkyle, (C3-C7 cycloalkyle, (C1-C6 alkyle-(C3-C7) cycloalkyle, (C3-C7 cycloalkyle-(C1-C6) alkyle, (3-7 membre) hétérocycloalkyle, phényle, (5-6 membre) hétéroaryle ou ORa. L'invention concerne également lesdits composés pour l'utilisation en thérapie, des compositions pharmaceutiques comprenant ces composés et des produits intermédiaires pour la préparation desdits composés.
AbstractList The present invention relates to a compound according to general formula (I) wherein X represents N or CH; R1 is -CN, (C1-C6)alkyl, (C3-C7)cycloalkyl, (3-7 membered)heterocycloalkyl, (5-6 membered)heteroaryl, (C3-C7)cycloalkyl(C1-C4)alkyl, (3-7 membered)heterocycloalkyl-(C1-C4)alkyl or (5-6 membered)heteroaryl- (C1-C4)alkyl; R2 is halogen, cyano, (C1-C4)alkyl or (C3-C7)cycloalkyl; R3 is halogen, cyano, (C1-C4)alkyl, (C1-C4)haloalkyl or (C3-C7)cycloalkyl; R4 is (C1-C4)alkyl or (C1-C4)haloalkyl; R5 is (C1-C6)alkyl, (C3-C7)cycloalkyl, (C1-C6)alkyl-(C3-C7)cycloalkyl, (C3-C7)cycloalkyl-(C1-C6)alkyl, (3-7 membered)heterocycloalkyl, phenyl, (5-6 membered)heteroaryl or -ORa. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds and to intermediates for preparation of said compounds. La présente invention concerne des composés selon la formule générale (I) où X représente N ou CH; R1 est -CN, (C1-C6alkyle, (C3-C7 cycloalkyle, (3-7 membre)hétérocycloalkyle, (5-6 membre)hétéroaryle, (C3-C7) cycloalkyle (C1-C4 alkyle, (3-7 membre) hétérocycloalkyle-(C1-C4 alkyle ou (5-6 membre) hétéroaryle-(C1-C4 alkyle; R2 est un halogène, un cyano, (C1-C4 alkyle ou (C3-C7 cycloalkyle; R3 est un halogène, un cyano, (C1-C4 alkyle, (C1-C4 haloalkyle ou (C3-C7) cycloalkyle; R4 est (C1-C4 alkyle ou (C1-C4 haloalkyle; R5 est (C1-C6 alkyle, (C3-C7 cycloalkyle, (C1-C6 alkyle-(C3-C7) cycloalkyle, (C3-C7 cycloalkyle-(C1-C6) alkyle, (3-7 membre) hétérocycloalkyle, phényle, (5-6 membre) hétéroaryle ou ORa. L'invention concerne également lesdits composés pour l'utilisation en thérapie, des compositions pharmaceutiques comprenant ces composés et des produits intermédiaires pour la préparation desdits composés.
Author SØRENSEN, Morten Dahl
JESSIMAN, Alan Stuart
JOHNSON, Patrick Stephen
MAANSSON, Kristoffer
Author_xml – fullname: JOHNSON, Patrick Stephen
– fullname: MAANSSON, Kristoffer
– fullname: JESSIMAN, Alan Stuart
– fullname: SØRENSEN, Morten Dahl
BookMark eNqNij0LwjAQQDPo4Nd_CDgXGl1cj-TaBEyvxBPHUuScJC3U_48Z_AFOD957W7XKU5aNaj0yJoJEEThYHcndr8CUbpoazR51Qg4dBVclLAGdptR76Iq32JdRtxAj7NX6Nb4XOfy4U8cG2fpK5mmQZR6fkuUzPOhUm0ttTAGY83_XF89wL04
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate MODULATEURS HÉTÉROAROMATIQUES DU RÉCEPTEUR GAMMA ORPHELIN ASSOCIÉ AUX RÉTINOÏDES
ExternalDocumentID WO2018011201A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2018011201A13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:56:40 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2018011201A13
Notes Application Number: WO2017EP67390
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180118&DB=EPODOC&CC=WO&NR=2018011201A1
ParticipantIDs epo_espacenet_WO2018011201A1
PublicationCentury 2000
PublicationDate 20180118
PublicationDateYYYYMMDD 2018-01-18
PublicationDate_xml – month: 01
  year: 2018
  text: 20180118
  day: 18
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies LEO PHARMA A/S
RelatedCompanies_xml – name: LEO PHARMA A/S
Score 3.1252306
Snippet The present invention relates to a compound according to general formula (I) wherein X represents N or CH; R1 is -CN, (C1-C6)alkyl, (C3-C7)cycloalkyl, (3-7...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title HETEROAROMATIC MODULATORS OF THE RETINOID-RELATED ORPHAN RECEPTOR GAMMA
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180118&DB=EPODOC&locale=&CC=WO&NR=2018011201A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8BhT1Dedih9TCkrfivZj3fYwJEvTdWKbUjvd22iWFgTphqv4972UTfe0p3xyHBfuK5fLAdwX0hSuK2zDsmTXcPpmYWRWLg08f1s4wskyqSK6YeQGE-d52pk24HOTC1P_E_pTf46IHDVHfq9qeb38v8Ty6reVqwfxgVOLJz8dePraOzZ7KpFS94YDFnOPU51S9Nv0KNmsYUPQV9pDQ7qr-IG9DVVeynJbqfjHsB8jvLI6gUZetuCQbmqvteAgXIe8sbvmvtUpjAKGxicnCQ9JOqZayL3JC0l58qpxX0sDpiUsHUd87BmqEgbKJI0ncUAinKcsxo3aiIQhOYM7n6U0MBCj2R8BZu98G337HJrloswvQJNI6X7hdFTAxBHyUZh2ZuZWgWo3cy1ZXEJ7F6Sr3cvXcKSG6sLB7LWhWX195zeogitxW1PuF9MNg4c
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LH1ILSt6L9WLc9DMnadK2uTamZ7m00tgVBuuEq_vteyqZ72lNCLoTjwi-Xu8tdAO6KTBe2LUzNMLKuZvX1QkuNPNNw_01hCStNMxnRDSPbn1hP0860AZ_rXJi6TuhPXRwREfWOeK_q83rx78Ry67eVy3vxgUPzR48PXHVlHes9mUipusMBjZnLHNVx0G5To2RNw4agrbSDl-yuxAN9Hcq8lMWmUvEOYTfG9crqCBp52YJ9Z_33Wgv2wlXIG7sr9C2PYeRTvHwykrCQ8MBRQuZOxoSz5EVhnsJ9qiSUBxELXE3-hIFnksKS2CcRjjs0xonKiIQhOYFbj3LH15Cj2Z8AZm9sk33zFJrlvMzPQMlQ0v3C6siAiSWyB6GbqZ4bBard1Day4hza21a62E6-gX2fh-PZOIieL-FAkqTzQe-1oVl9fedXqI4rcV1L8RcqJoZ6
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HETEROAROMATIC+MODULATORS+OF+THE+RETINOID-RELATED+ORPHAN+RECEPTOR+GAMMA&rft.inventor=JOHNSON%2C+Patrick+Stephen&rft.inventor=MAANSSON%2C+Kristoffer&rft.inventor=JESSIMAN%2C+Alan+Stuart&rft.inventor=S%C3%98RENSEN%2C+Morten+Dahl&rft.date=2018-01-18&rft.externalDBID=A1&rft.externalDocID=WO2018011201A1